HK1017615A1 - Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases. - Google Patents

Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases.

Info

Publication number
HK1017615A1
HK1017615A1 HK99102826A HK99102826A HK1017615A1 HK 1017615 A1 HK1017615 A1 HK 1017615A1 HK 99102826 A HK99102826 A HK 99102826A HK 99102826 A HK99102826 A HK 99102826A HK 1017615 A1 HK1017615 A1 HK 1017615A1
Authority
HK
Hong Kong
Prior art keywords
asa
treatment
pharmaceutical composition
bowel diseases
modified release
Prior art date
Application number
HK99102826A
Other languages
English (en)
Inventor
Svenn Kluever Jepsen
Soren Halskov
Original Assignee
Ferring Farma Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24302375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1017615(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Farma Lab filed Critical Ferring Farma Lab
Publication of HK1017615A1 publication Critical patent/HK1017615A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
HK99102826A 1995-12-21 1999-07-05 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases. HK1017615A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57595495A 1995-12-21 1995-12-21
PCT/DK1996/000551 WO1997023199A1 (fr) 1995-12-21 1996-12-23 Composition pharmaceutique orale a liberation modifiee contenant 5-asa et procede de traitement de maladies intestinales

Publications (1)

Publication Number Publication Date
HK1017615A1 true HK1017615A1 (en) 1999-11-26

Family

ID=24302375

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99102826A HK1017615A1 (en) 1995-12-21 1999-07-05 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases.

Country Status (28)

Country Link
EP (1) EP0871434B2 (fr)
JP (1) JP4714836B2 (fr)
KR (2) KR100598714B1 (fr)
CN (1) CN1155369C (fr)
AT (1) ATE205704T1 (fr)
AU (1) AU702934B2 (fr)
BG (1) BG63484B1 (fr)
BR (1) BR9612213A (fr)
CA (1) CA2240281C (fr)
CZ (1) CZ289290B6 (fr)
DE (2) DE871434T1 (fr)
DK (1) DK0871434T4 (fr)
EE (1) EE03740B1 (fr)
ES (1) ES2149733T5 (fr)
HK (1) HK1017615A1 (fr)
HU (1) HU228856B1 (fr)
IL (1) IL124858A (fr)
IS (1) IS1834B (fr)
NO (1) NO320498B1 (fr)
NZ (1) NZ325201A (fr)
PL (1) PL186790B1 (fr)
PT (1) PT871434E (fr)
RU (1) RU2181043C2 (fr)
SI (1) SI0871434T2 (fr)
SK (1) SK282669B6 (fr)
TR (1) TR199801158T2 (fr)
UA (1) UA67721C2 (fr)
WO (1) WO1997023199A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
DK1146862T3 (da) 1999-01-29 2003-07-21 Disphar Int Bv Farmaceutiske sammensætninger
CA2359812C (fr) 2000-11-20 2004-02-10 The Procter & Gamble Company Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures
MXPA04003506A (es) * 2001-10-15 2004-07-23 Ferring Bv Metodo para la preparacion de una composicion farmaceutica que comprende acido 5-aminosalicilico para el uso en el tratamiento de la colitis ulcerativa y de la enfermedad de crohn.
US8282955B2 (en) * 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
JP2007523664A (ja) * 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ 医薬組成物用サシェ
EP1547601A1 (fr) 2003-12-23 2005-06-29 Ferring B.V. Procédé de revêtement
RU2297835C1 (ru) 2005-09-26 2007-04-27 Закрытое акционерное общество "Партнер" Препарат для лечения неинфекционных воспалительных болезней кишечника
JP5450053B2 (ja) * 2006-04-13 2014-03-26 ニューロテック ファーマシューティカルズ カンパニー リミテッド 細胞損傷及び炎症疾患の治療または予防用薬学組成物
US8569375B2 (en) * 2008-08-22 2013-10-29 Reckitt Benckiser Healthcare (Uk) Limited Compositions
AU2009298139B2 (en) 2008-10-03 2015-02-19 Dr. Falk Pharma Gmbh Compositions and methods for the treatment of bowel diseases with granulated mesalamine
EP2340812A1 (fr) 2009-12-18 2011-07-06 Ferring International Center S.A. Granules pour préparations pharmaceutiques, procédés et appareil pour leur production
RU2463055C2 (ru) * 2011-01-12 2012-10-10 Петр Леонидович Щербаков Способ лечения воспалительных заболеваний кишечника
CN102319218B (zh) * 2011-09-22 2014-10-01 贝沃特医药技术(上海)有限公司 一种治疗肠道疾病的药物缓控释微粒制剂及其制备方法
WO2013144176A1 (fr) 2012-03-30 2013-10-03 Laboratorios Del Dr. Esteve, S.A. Formulation à libération contrôlée comprenant de la mésalamine
RU2752082C1 (ru) * 2020-09-29 2021-07-22 федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство с гранулами, содержащими 5-аминосалициловую кислоту и фолиевую кислоту, с контролируемым высвобождением

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002671A1 (fr) * 1980-03-20 1981-10-01 Ferring Farma Lab Composition pharmaceutique et methode de traitement de la colite ulcereuse et la maladie de crohn par voie orale
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
GB8926639D0 (en) * 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon

Also Published As

Publication number Publication date
CZ289290B6 (cs) 2001-12-12
SK83498A3 (en) 1999-01-11
BG63484B1 (bg) 2002-03-29
IL124858A (en) 2003-03-12
BG102556A (en) 1999-02-26
PL186790B1 (pl) 2004-02-27
EE03740B1 (et) 2002-06-17
NZ325201A (en) 1998-11-25
UA67721C2 (en) 2004-07-15
HUP0001084A3 (en) 2000-12-28
JP4714836B2 (ja) 2011-06-29
CN1155369C (zh) 2004-06-30
JPH11510191A (ja) 1999-09-07
AU1366197A (en) 1997-07-17
AU702934B2 (en) 1999-03-11
TR199801158T2 (xx) 1998-09-21
DE69615400T3 (de) 2008-08-07
KR19990076584A (ko) 1999-10-15
PL327323A1 (en) 1998-12-07
IL124858A0 (en) 1999-01-26
ES2149733T5 (es) 2008-05-01
NO982904D0 (no) 1998-06-22
IS4772A (is) 1998-06-15
DE871434T1 (de) 2001-04-05
CA2240281A1 (fr) 1997-07-03
RU2181043C2 (ru) 2002-04-10
IS1834B (is) 2002-11-15
ATE205704T1 (de) 2001-10-15
CZ194698A3 (cs) 1998-10-14
NO982904L (no) 1998-06-22
ES2149733T1 (es) 2000-11-16
KR100598714B1 (ko) 2006-07-10
BR9612213A (pt) 1999-12-28
DK0871434T4 (da) 2008-04-07
EP0871434B2 (fr) 2007-12-12
NO320498B1 (no) 2005-12-12
EE9800191A (et) 1998-12-15
EP0871434B1 (fr) 2001-09-19
SI0871434T2 (sl) 2008-04-30
PT871434E (pt) 2002-02-28
ES2149733T3 (es) 2002-04-01
SK282669B6 (sk) 2002-11-06
KR100542544B1 (ko) 2006-05-10
DK0871434T3 (da) 2002-01-07
CA2240281C (fr) 2007-02-27
DE69615400D1 (de) 2001-10-25
HUP0001084A2 (hu) 2000-11-28
EP0871434A1 (fr) 1998-10-21
DE69615400T2 (de) 2002-05-23
KR20050087886A (ko) 2005-08-31
HU228856B1 (en) 2013-06-28
CN1207672A (zh) 1999-02-10
SI0871434T1 (en) 2002-04-30
WO1997023199A1 (fr) 1997-07-03

Similar Documents

Publication Publication Date Title
HK1017615A1 (en) Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases.
IL118240A (en) Oral coated capsule dosage form of omega-3 polyunsaturated acid for release of the acid in the intestine
MY104535A (en) Oral composition for the treatment of inflammatory bowel diseases.
DE69720985D1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
DE69629797D1 (de) Matrix zur gesteuerten freisetzung von arzneistoffen
ZA935650B (en) Pelletised pharmaceutical composition
FI943315A (fi) Farmaseuttinen valmiste pore- ja/tai hajoamistabletin tai pikarakeiden muodossa, samoin kuin menetelmä valmistaa niitä
MXPA04003506A (es) Metodo para la preparacion de una composicion farmaceutica que comprende acido 5-aminosalicilico para el uso en el tratamiento de la colitis ulcerativa y de la enfermedad de crohn.
MY137570A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis crohn's disease
DE69634080D1 (de) Mittel zur verhinderung der truebung der vorderen linsenkapsel

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20161222